Literature DB >> 18728932

Cystatin C as a filtration marker--haemodialysis patients expose its strengths and limitations.

Per A Sjöström1, Ian L Jones, Martin A Tidman.   

Abstract

OBJECTIVE: The reliability of serum cystatin C (s-Cys) as a filtration marker depends on the intra- and inter-individual variation and influence of non-renal factors of its production rate (Cys(pr)), non-renal clearance (CL(nr)) and sieving coefficient (S). Haemodialysis patients with no residual renal function would be the best population in which to investigate these variables, which otherwise require reliable GFR measurements.
MATERIAL AND METHODS: Seventy-nine haemodialysis (HD) patients with negligible residual renal function (Group 1) were investigated and compared with 55 HD patients with varying degrees of residual renal function (Group 2) and 923 non-dialysis patients (Group 3). The equation eGFR = Cys(pr)/s-Cys-CL(nr) was used to analyse the turnover and variation of cystatin C.
RESULTS: A formula for estimating GFR, eGFR = 99/s-Cys-14.1, calculated from Group 3, was shown to fit the HD patients. The measured s-Cys in Group 1 was 6.9+/-0.9 and 6.4+/-1.1 mg/L in Group 2. The calculated 95% confidence interval of eGFR of +/-(30-40) % increased sharply below GFR 20 mL/min/1.73 m(2), which means that s-Cys cannot be used for calculating low GFR, including the residual GFR of dialysis patients.
CONCLUSIONS: Nicotine users in Group 1 had significantly higher s-Cys than non-users (7.5+/-0.9 mg/L compared to 6.7+/-0.8; p = 0.0008), which may be a factor to include in the eGFR formulae. However, s-Cys was independent of non-renal factors such as sex, age, LBM, body weight, malnutrition and CRP and also of changes in CRP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18728932     DOI: 10.1080/00365510802326469

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  6 in total

1.  Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin renal clearance.

Authors:  Masaru Horio; Enyu Imai; Yoshinari Yasuda; Tsuyoshi Watanabe; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2011-08-24       Impact factor: 2.801

2.  Removal and rebound kinetics of cystatin C in high-flux hemodialysis and hemodiafiltration.

Authors:  Enric Vilar; Capella Boltiador; Adie Viljoen; Ashwini Machado; Ken Farrington
Journal:  Clin J Am Soc Nephrol       Date:  2014-05-01       Impact factor: 8.237

Review 3.  Role of biomarkers of nephrotoxic acute kidney injury in deliberate poisoning and envenomation in less developed countries.

Authors:  Fahim Mohamed; Zoltan H Endre; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2015-05-28       Impact factor: 4.335

4.  Cystatin C in children on chronic hemodialysis.

Authors:  Olivera Marsenic; Andrea Wierenga; Donna R Wilson; Michael Anderson; Tripti Shrivastava; Garfield A Simon; Anne M Beck; Tiffany J Swanson; Kathleen Studnicka; Dorit Elberg; Kevin Couloures; Martin A Turman
Journal:  Pediatr Nephrol       Date:  2012-11-21       Impact factor: 3.714

5.  Measured glomerular filtration rate does not improve prediction of mortality by cystatin C and creatinine.

Authors:  Per-Ola Sundin; Per Sjöström; Ian Jones; Lovisa A Olsson; Ruzan Udumyan; Anders Grubb; Veronica Lindström; Scott Montgomery
Journal:  Nephrol Dial Transplant       Date:  2017-04-01       Impact factor: 5.992

6.  Multicenter study of creatinine- and/or cystatin C-based equations for estimation of glomerular filtration rates in Chinese patients with chronic kidney disease.

Authors:  Jia-fu Feng; Ling Qiu; Lin Zhang; Xue-mei Li; Yu-wei Yang; Ping Zeng; Xiu-zhi Guo; Yan Qin; Hong-chun Liu; Xing-min Han; Yan-peng Li; Wei Xu; Shu-yan Sun; Li-qiang Wang; Hui Quan; Li-jun Xia; Hong-zhang Hu; Fang-cai Zhong; Rong Duan
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.